Business Context and Reporting Period
This Form 6-K filing by Can-Fite Biopharma Ltd. covers the month of December 2014. The report addresses a corporate governance event regarding a Special General Meeting of Shareholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a notice regarding a shareholder meeting and contains no financial statements or performance data.
Material Changes
No material financial changes versus the prior comparable period are reported in this document.
Outlook, Risks, and Unusual Items
Shareholder Meeting Adjournment: On December 24, 2014, the Company convened a Special General Meeting of Shareholders. The meeting was adjourned for one week due to a lack of quorum.
Reconvened Meeting Details: The Special Meeting is scheduled to be reconvened on Wednesday, December 31, 2014, at 10:00 am Israel time at the Company's offices in Petach Tikva, Israel.
Key Facts for Investor Verification
- Verify the outcome of the Special General Meeting reconvened on December 31, 2014.
- Confirm the specific agenda items intended for the Special Meeting, as they are not detailed in this filing.
- Check subsequent filings for any financial updates or results stemming from the shareholder vote.